MARC2 抗体
(Mitochondrial Amidoxime Reducing Component 2 (MARC2))
As a component of the benzamidoxime prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively (By similarity).
Recommended next Filters:
您想试用我们的人工智能搜索吗？
23 results
Latest Publications for our MARC2 抗体
: "Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran." in: PLoS ONE, Vol. 10, Issue 9, pp. e0138487, (2015) (PubMed).: "The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice." in: PloS one, Vol. 9, Issue 8, pp. e105371, (2014) (PubMed).
: "Global profiling of co- and post-translationally N-myristoylated proteomes in human cells." in: Nature communications, Vol. 5, pp. 4919, (2014) (PubMed).
: "Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells." in: Nature methods, Vol. 10, Issue 4, pp. 315-23, (2013) (PubMed).
Aliases for MARC2 抗体
mitochondrial amidoxime reducing component 1 (MARC1) 抗体mitochondrial amidoxime reducing component 2 (MARC2) 抗体
mitochondrial amidoxime reducing component 2 (Marc2) 抗体
2810484M10Rik 抗体
mARC1 抗体
mARC2 抗体
Mg87 抗体
MOSC2 抗体
Mosc2 抗体
RP11-270A6.1 抗体
您还需要查找其他产品吗？
You are here:
